Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 1 Neoplasms 1 Mental Fatigue 1 Fatigue 1

Interventions

pembrolizumab 38 Bevacizumab 25 Cyclophosphamide 22 Blood Specimen Collection 18 Nivolumab 17 Carboplatin 16 Standard of Care 14 Paclitaxel 14 atezolizumab 13 Gemcitabine 13 Exercise 13 Pemetrexed 12 Cisplatin 12 Fluorouracil 11 Doxorubicin 11 Cetuximab 10 Radiotherapy 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Docetaxel 9 durvalumab 8 abemaciclib 8 Temozolomide 8 Surveys and Questionnaires 8 Rituximab 8 Prednisone 8 Dexamethasone 8 Biopsy 8 130-nm albumin-bound paclitaxel 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Sildenafil Citrate × 90 days × Clear all

NCT06800092 2026-05-11

SPARC

The University of Texas Medical Branch, Galveston

Phase 2/3 Not yet recruiting

Fatigue, Mental Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡